Mauricio Monaco

Statistics

Publications

Citations

135

H-Index

Active since

2017

Affiliations

Sarah Cannon(Current)

Texas Oncology

Instituto de Investigación Biomédica de Málaga

Hospital Clínico Universitario Virgen de la Victoria

Institut de Cancérologie de l'Ouest

Mauricio Monaco is an author at Sarah Cannon specializing in human epidermal growth factor receptor 2-targeted therapy, breast cancer hormone therapy, and hormonal therapy.

Publications per year

2017–2018

Publications

Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2

Sunil Verma, Joyce O’Shaughnessy, Howard A. Burris et al. · Breast Cancer Research and Treatment · 2018 · 93 citations · Full text

Medicine, Oncology, Pharmacology +16

Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2&minus; advanced breast cancer

Gabriel Tremblay, David Chandiwana, Mike Dolph et al. · Cancer Management and Research · 2018 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

Health-related quality of life (HRQoL) of postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) treated with ribociclib + letrozole: Results from MONALEESA-2.

Sunil Verma, Joyce O’Shaughnessy, Howard A. Burris et al. · Journal of Clinical Oncology · 2017 · 16 citations

Medicine, Oncology, Pharmacology +17

1–3 of 3